Abstract

Malaria is responsible for more deaths around the world than any other parasitic disease. Due to the emergence of strains that are resistant to the current chemotherapeutic antimalarial arsenal, the search for new antimalarial drugs remains urgent though hampered by a lack of knowledge regarding the molecular mechanisms of artemisinin resistance. Semisynthetic compounds derived from diterpenes from the medicinal plant Wedelia paludosa were tested in silico against the Plasmodium falciparum Ca2+-ATPase, PfATP6. This protein was constructed by comparative modelling using the three-dimensional structure of a homologous protein, 1IWO, as a scaffold. Compound 21 showed the best docking scores, indicating a better interaction with PfATP6 than that of thapsigargin, the natural inhibitor. Inhibition of PfATP6 by diterpene compounds could promote a change in calcium homeostasis, leading to parasite death. These data suggest PfATP6 as a potential target for the antimalarial ent-kaurane diterpenes.

Highlights

  • Malaria is the most widespread infectious parasitic disease around the world (WHO 2013)

  • Among the numerous genes involved in artemisinin resistance, PfATP6, a sarco/endoplasmic reticulum Ca2+ATPase (SERCA) homologue expressed in Plasmodium falciparum, has been suggested as a possible target of artemisinin (Valderramos et al 2010, Cui et al 2012)

  • Financial support: FAPEMIG, CNPq + Corresponding author: varotti@ufsj.edu.br Received 4 November 2014 Accepted 29 January 2015 al. 2014) we investigated the interaction between the entkaurane diterpenes and PfATP6 (Gardner et al 2002)

Read more

Summary

Introduction

Malaria is the most widespread infectious parasitic disease around the world (WHO 2013). Due to the selective antimalarial activity exhibited by these compounds and knowing that diterpenes induce calcium overload in myocytes Molecular mechanisms that maintain parasite calcium homeostasis are controlled by proteins such as PfATP6 (Krishna et al 2010).

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call